Clinical Trial – Treatment of Pancreatic Cancer With Abraxane – Pancreatic Cancer

This observational program is aimed at gaining tolerability, safety and efficacy data with the routine use of Abraxane in its labeled indication in metastatic pancreatic cancer. Additionally data on real life dosing in daily clinical routine will be analyzed.

A detailed record of the medical history including co-morbidities and pre-treatment regimens will allow analysis of the impact thereof on tolerability, dosage and efficacy. Hands-on experience with nab-paclitaxel is very limited in Austria and an non-interventional study could enhance knowledge on optimal drug handling and Adverse Event management.

Study Type  : Observational
Estimated Enrollment  : 75 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Multicenter Non-interventional Study to Investigate Safety, Tolerability and Efficacy of Nab-paclitaxel in Clinical Routine Treatment of First-line Pancreatic Cancer Patients
Actual Study Start Date  : May 8, 2015
Estimated Primary Completion Date  : March 31, 2019
Estimated Study Completion Date  : July 31, 2019

Contacts
Contact: Associate Director Clinical Trial Disclosure 1-888-260-1599 clinicaltrialdisclosure@celgene.com
Locations
Austria
BHB Eisenstadt Recruiting
Eisenstadt, Austria, 7001
LKH Feldkirch Recruiting
Feldkirch, Austria, 6800:
Medical University Graz Recruiting
Graz, Austria, 8010
Medical University Innsbruck Recruiting
Innsbruck, Austria, 6020:
KH Elisabethinen Klagenfurt Recruiting
Klagenfurt, Austria, 9020
LKH Klagenfurt Recruiting
Klagenfurt, Austria, 9020
KH Krems Recruiting
Krems, Austria, 3500
LKH Leoben Enrolling by invitation
Leoben, Austria, 8700:
KH Barmherzige Schwestern Linz Recruiting
Linz, Austria, 4020:
LKH Salzburg Recruiting
Salzburg, Austria, 5020:
LKH St. Pölten Recruiting
St. Pölten, Austria, 3100:
LKH Steyr Recruiting
Steyr, Austria, 4400:
Medical University Vienna Recruiting
Vienna, Austria, 1090:
KH St. Josephs Recruiting
Vienna, Austria, 1130
KH Hanusch Recruiting
Vienna, Austria, 1140
KH SMZ Ost Completed
Vienna, Austria, 1220:
LKH Vöcklabruck Recruiting
Vöcklabruck, Austria, 4840:
Klinikum Wels Recruiting
Wels, Austria, 4600:
LKH Wr. Neustadt Recruiting
Wr. Neustadt, Austria, 2700:
KH Zams Recruiting
Zams, Austria, 6511

 

ClinicalTrials.gov Identifier: NCT02555813

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.